RN7SKP141

Across TCGA pan-cancer cohorts, RN7SKP141 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RN7SKP141 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher RN7SKP141 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP141 expression acts as an unfavorable survival marker, although some lineages such as STAD and ESCA show a favorable association.

KIRC, THCA, and ACC are the cancer types where RN7SKP141 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.517	0.881	<.001	108	view →
THCA	OS	Tertile	All	0.173	0.952	<.001	63	view →
ACC	DFS	Tertile	All	0.131	0.607	.002	60	view →
LGG	OS	Tertile	All	0.250	0.830	.001	36	view →
PAAD	OS	Tertile	II,III,IV	0.210	0.556	.007	18	view →
STAD	OS	Tertile	IV	1.000	0.299	.047	6	view →
ESCA	DFS	Tertile	All	0.622	0.334	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RN7SKP141–KIRC (OS)

Open the KIRC breakdown →